Plasma Endothelial Microparticles, TNF-a and IL-6 in Kawasaki Disease

Zhen Tan1, Yan Yuan, Sun Chen

  • 1Department of Pediatrics, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, China, 200092.

Indian Pediatrics
|December 21, 2012
PubMed

Insights

Endothelial microparticles (EMPs) and IL-6 are elevated in Kawasaki disease (KD). EMPs, a marker of endothelial damage, correlate with TNF-a and IL-6, indicating systemic inflammation in KD patients.

Area of Science:

  • Biochemistry
  • Immunology
  • Pediatric Medicine

Background:

  • Kawasaki disease (KD) is an acute febrile vasculitis affecting medium-sized arteries, primarily in children.
  • Endothelial dysfunction is a key feature of KD, but specific biomarkers require further investigation.
  • Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-a) are known inflammatory cytokines implicated in KD pathogenesis.

Purpose of the Study:

  • To investigate the levels of endothelial microparticles (EMPs), IL-6, and TNF-a in patients diagnosed with Kawasaki disease.
  • To explore the relationship between EMPs, inflammatory markers (IL-6, TNF-a), and clinical parameters in KD.

Main Methods:

  • Endothelial microparticles (EMPs) were quantified using flow cytometry.
  • Serum levels of IL-6 and TNF-a were measured via enzyme-linked immunosorbent assay (ELISA).
  • Statistical analyses were performed to correlate biomarker levels with disease status and clinical factors.

Main Results:

  • Patients with KD exhibited significantly elevated levels of EMPs and IL-6 compared to healthy controls.
  • TNF-a levels were higher in KD patients than in healthy controls, but not significantly different from disease controls.
  • A positive correlation was observed between EMP levels and TNF-a, and a negative correlation between EMPs and albumin.

Conclusions:

  • Elevated EMPs, indicative of endothelial cell damage, are present in Kawasaki disease patients.
  • The findings suggest a role for endothelial activation and inflammation, involving IL-6 and TNF-a, in the pathophysiology of KD.
  • EMPs may serve as a valuable biomarker for endothelial injury in KD.

Related Concept Videos

Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...